Prostatic Neoplasms Clinical Trials
3 recruiting trials for Prostatic Neoplasms. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 2NCT05616650
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
Background: The current standard treatment of prostate cancer is either surgery or radiation. Typically, this includes either the removal or radiation of the whole prostate...
Sponsor: National Cancer Institute (NCI)Enrolling: 421 location
RECRUITINGNCT07451002
A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France
This study aims to explore the real-world treatment adherence, persistence of apalutamide, and assess the risk of non-adherence according to the participant's profile and behavior...
Sponsor: Janssen Cilag S.A.S.Enrolling: 2701 location
RECRUITINGPhase 2NCT05765500
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
This study is testing the way that approved androgen deprivation therapy treatments, Leuprolide and Relugolix, for prostate cancer affect quality of life, blood levels,...
Sponsor: Dana-Farber Cancer InstituteEnrolling: 1103 locations